首页> 外文OA文献 >Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial

【2h】

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial

机译：曲妥珠单抗联合奥沙利铂/卡培他滨用于HER2阳性晚期胃癌（CGOG1001）一线治疗的最佳方案：一项多中心II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial [J] . Jifang Gong, Tianshu Liu, Qingxia Fan, BMC Cancer . 2016,第1期

机译：曲妥珠单抗联合奥沙利铂/卡培他滨治疗HER2阳性晚期胃癌（CGOG1001）一线治疗的最佳方案：一项多中心II期试验
3. Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial (vol 83, pg 1175, 2019) [J] . Rivera Fernando, Romero C., Jimenez-Fonseca P., Cancer chemotherapy and pharmacology. . 2019,第6期

机译：II期研究以评估曲妥珠单抗与己二维汀和奥沙利铂组合的疗效在一线治疗Her2阳性晚期胃癌中：Herxo试验（Vol 83，PG 1175,2019）
4. Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial [J] . Rivera Fernando, Romero C., Jimenez-Fonseca P., Cancer chemotherapy and pharmacology. . 2019,第6期

机译：II期研究以评估曲妥珠单抗与己二维滨和奥沙利铂组合的疗效在英雄阳性晚期胃癌中的一线治疗中：Herxo试验
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. Prospective Phase II Multicenter Registry of Ablation after Breast Lumpectomy Added to Extend (ABLATE) Intraoperative Margins in the Treatment of Breast Cancer [D] . Klimberg, V. Suzanne. 2017

机译：乳房肿块切除术后消融的前瞻性II期多中心消融术增加了扩大（ABLATE）术中切缘在治疗乳腺癌中的作用
7. Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter phase II trial [O] . Jifang Gong, Tianshu Liu, Qingxia Fan, 2016

机译：曲妥珠单抗联合奥沙利铂/卡培他滨用于HER2阳性晚期胃癌（CGOG1001）一线治疗的最佳方案：一项多中心II期试验
8. A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer [O] . Y-K Kang, S Y Rha, P Tassone, 2014

机译：患有Her2阳性晚期胃癌患者的曲妥珠单抗，Capecitabine和顺铂组合的IIA型钙菌，综合系剂的蛋白质剂量研究和安全性研究

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial

著录项

引文网络

相似文献

相关主题

期刊订阅